삼오제약

삼오제약 is a declared insider of 아미노로직스, with filings sourced from DART (FSS). We count 7 filings; the first trade dates from 10 July 2026 and the latest from 2 October 2026.

The open-market side counts 1 purchase alongside 2 sales. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

On 2 October 2026 came the latest disclosure, a transaction in 아미노로직스. The most recent open-market purchase was published on 13 July 2026, 118 days ago. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from DART (FSS). Past trades are no guide to future returns.